Trial Outcomes & Findings for Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses (NCT NCT06461455)

NCT ID: NCT06461455

Last Updated: 2025-12-24

Results Overview

Visual Acuity (VA) was assessed at a distance of 4 meters with both eyes together (binocular) under high contrast, high illumination lighting with study lenses in place. VA was measured using letter charts and recorded in the logarithm of the minimum angle of resolution (LogMAR). A LogMAR value of 0 equates to 20/20 Snellen VA (normal distance eyesight), with negative LogMAR values representing better than 20/20 VA. The LogMAR VA scale ranges from -0.30 (20/10 Snellen) to 1.00 (20/200 Snellen).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

95 participants

Primary outcome timeframe

Day 30 (-2/+1) of each wear period. A wear period was 30 days (-2/+1) according to randomization assignment.

Results posted on

2025-12-24

Participant Flow

Subjects were enrolled at 11 investigative sites.

Of the 95 enrolled, 6 subjects were discontinued as screen failures prior to randomization, and 4 subjects were discontinued post randomization and prior to exposure to the study lenses. This reporting group includes all subjects exposed to any study lenses evaluated in this study.

Participant milestones

Participant milestones
Measure
LID230451, Then ULTRA MFfA
Lehfilcon A multifocal for astigmatism contact lenses worn in Period 1, followed by samfilcon A multifocal for astigmatism contact lenses worn in Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
ULTRA MFfA, Then LID230451
Samfilcon A multifocal for astigmatism contact lenses worn in Period 1, followed by lehfilcon A multifocal for astigmatism contact lenses worn in Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
First Wear Period (Approx 30 Days)
STARTED
46
39
First Wear Period (Approx 30 Days)
COMPLETED
45
38
First Wear Period (Approx 30 Days)
NOT COMPLETED
1
1
Washout Period (Approx 2-4 Days)
STARTED
45
38
Washout Period (Approx 2-4 Days)
COMPLETED
45
37
Washout Period (Approx 2-4 Days)
NOT COMPLETED
0
1
Second Wear Period (Approx 30 Days)
STARTED
45
37
Second Wear Period (Approx 30 Days)
COMPLETED
45
37
Second Wear Period (Approx 30 Days)
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
LID230451, Then ULTRA MFfA
Lehfilcon A multifocal for astigmatism contact lenses worn in Period 1, followed by samfilcon A multifocal for astigmatism contact lenses worn in Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
ULTRA MFfA, Then LID230451
Samfilcon A multifocal for astigmatism contact lenses worn in Period 1, followed by lehfilcon A multifocal for astigmatism contact lenses worn in Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
First Wear Period (Approx 30 Days)
Withdrawal by Subject
0
1
First Wear Period (Approx 30 Days)
Screen failure
1
0
Washout Period (Approx 2-4 Days)
Adverse Event
0
1

Baseline Characteristics

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
LID230451, Then ULTRA MFfA
n=46 Participants
Lehfilcon A multifocal for astigmatism contact lenses worn in Period 1, followed by samfilcon A multifocal for astigmatism contact lenses worn in Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
ULTRA MFfA, Then LID230451
n=39 Participants
Samfilcon A multifocal for astigmatism contact lenses worn in Period 1, followed by lehfilcon A multifocal for astigmatism contact lenses worn in Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
Total
n=85 Participants
Total of all reporting groups
Age, Continuous
55.8 years
STANDARD_DEVIATION 9.4 • n=30 Participants
55.9 years
STANDARD_DEVIATION 9.4 • n=30 Participants
55.9 years
STANDARD_DEVIATION 9.4 • n=60 Participants
Sex: Female, Male
Female
29 Participants
n=30 Participants
27 Participants
n=30 Participants
56 Participants
n=60 Participants
Sex: Female, Male
Male
17 Participants
n=30 Participants
12 Participants
n=30 Participants
29 Participants
n=60 Participants
Race/Ethnicity, Customized
White
39 Participants
n=30 Participants
27 Participants
n=30 Participants
66 Participants
n=60 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants
n=30 Participants
2 Participants
n=30 Participants
4 Participants
n=60 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants
n=30 Participants
0 Participants
n=30 Participants
0 Participants
n=60 Participants
Race/Ethnicity, Customized
Asian
5 Participants
n=30 Participants
10 Participants
n=30 Participants
15 Participants
n=60 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants
n=30 Participants
0 Participants
n=30 Participants
0 Participants
n=60 Participants
Race/Ethnicity, Customized
Other
0 Participants
n=30 Participants
0 Participants
n=30 Participants
0 Participants
n=60 Participants
Region of Enrollment
United States
46 participants
n=30 Participants
39 participants
n=30 Participants
85 participants
n=60 Participants

PRIMARY outcome

Timeframe: Day 30 (-2/+1) of each wear period. A wear period was 30 days (-2/+1) according to randomization assignment.

Population: Full Analysis Set with data at visit

Visual Acuity (VA) was assessed at a distance of 4 meters with both eyes together (binocular) under high contrast, high illumination lighting with study lenses in place. VA was measured using letter charts and recorded in the logarithm of the minimum angle of resolution (LogMAR). A LogMAR value of 0 equates to 20/20 Snellen VA (normal distance eyesight), with negative LogMAR values representing better than 20/20 VA. The LogMAR VA scale ranges from -0.30 (20/10 Snellen) to 1.00 (20/200 Snellen).

Outcome measures

Outcome measures
Measure
LID230451
n=82 Participants
Lehfilcon A multifocal for astigmatism contact lenses worn in Period 1 or Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
ULTRA MFfA
n=81 Participants
Samfilcon A multifocal for astigmatism contact lenses worn in Period 1 or Period 2, as randomized. The study lenses were worn bilaterally (in both eyes) during typical contact lens wearing hours for at least 8 hours per day during each wear period \[30 days (-2/+1)\]. Study lenses were removed daily for cleaning and disinfection with CLEAR CARE.
Mean Binocular Visual Acuity at Distance (4 Meters) at Day 30 With Study Lenses
-0.50 logMAR
Standard Deviation 0.10
-0.08 logMAR
Standard Deviation 0.09

Adverse Events

Pretreatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID230451 Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

LID230451 Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

ULTRA MFfA Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

ULTRA MFfA Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sr. Principal, Clinical Project Management, Vision Care

Alcon Research, LLC

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER